Literature DB >> 12147546

Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats.

Katsufumi Sakata1, Hiroo Kumagai, Motohisa Osaka, Toshiko Onami, Tomokazu Matsuura, Masaki Imai, Takao Saruta.   

Abstract

BACKGROUND: Patients with a reduced nonlinear component of heart rate regulation have a poorer outcome. METHODS AND
RESULTS: We investigated whether a nonlinear correlation between renal sympathetic nerve activity (RSNA) and blood pressure or renal blood flow is reduced in conscious, spontaneously hypertensive rats (SHR) by comparing them with normotensive Wistar-Kyoto rats (WKY). We also determined the linearity and nonlinearity of the correlation in SHR who were given an angiotensin II receptor blocker, candesartan, orally for 2 weeks. The RSNA value was higher in SHR than in WKY, and coherence peaks of transfer function were found at 0.05 and 0.80 Hz (ie, below respiratory- and cardiac-related fluctuations). The coherence (linearity) of the transfer function was significantly higher and gain was smaller in SHR than in WKY. Because mutual information values (linear and nonlinear correlation) were similar in both strains, we found the nonlinear correlation to be lower in SHR than in WKY. Time delay values calculated by the mutual information method demonstrated that RSNA preceded blood pressure and renal blood flow by 0.5 to 1.0 s. In SHR given candesartan, the RSNA value was lower, and the linearity was lower and nonlinearity higher than SHR given vehicle.
CONCLUSIONS: Linear correlation between RSNA and blood pressure or renal blood flow was higher in SHR than in WKY, whereas the nonlinear correlation was lower. Oral treatment with candesartan increased the nonlinearity and reduced the linearity in SHR. Increased RSNA and the renin-angiotensin system may be responsible for the lower nonlinearity and higher linearity in hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147546     DOI: 10.1161/01.cir.0000023555.38685.5b

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

1.  An in vitro experimental model for analysis of central control of sympathetic nerve activity.

Authors:  Yuji Oyama; Kamon Iigaya; Yoshino Minoura; Toshitaka Okabe; Masahiko Izumizaki; Hiroshi Onimaru
Journal:  J Physiol Sci       Date:  2017-06-10       Impact factor: 2.781

2.  Cardiac innervation and sudden cardiac death.

Authors:  Masaki Ieda; Keiichi Fukuda
Journal:  Curr Cardiol Rev       Date:  2009-11

3.  Importance of rostral ventrolateral medulla neurons in determining efferent sympathetic nerve activity and blood pressure.

Authors:  Hiroo Kumagai; Naoki Oshima; Tomokazu Matsuura; Kamon Iigaya; Masaki Imai; Hiroshi Onimaru; Katsufumi Sakata; Motohisa Osaka; Toshiko Onami; Chie Takimoto; Tadashi Kamayachi; Hiroshi Itoh; Takao Saruta
Journal:  Hypertens Res       Date:  2011-12-15       Impact factor: 3.872

4.  Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yoshihiro Mori; Katsutoshi Hiramatsu; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-05-31       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.